Page last updated: 2024-11-03

opc 12759 and Adverse Drug Event

opc 12759 has been researched along with Adverse Drug Event in 2 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Research Excerpts

ExcerptRelevanceReference
"Aphthous stomatitis is induced by chemotherapy and radiotherapy."2.61[Development of Hospital Formulations Based on Medical Need]. ( Hanawa, T; Kawano, Y, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Yang, BR1
Lee, JY1
Kim, MG1
Kawano, Y1
Hanawa, T1

Reviews

1 review available for opc 12759 and Adverse Drug Event

ArticleYear
[Development of Hospital Formulations Based on Medical Need].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2019, Volume: 139, Issue:10

    Topics: Alanine; Cellulose; Chemical Phenomena; Drug Compounding; Drug-Related Side Effects and Adverse Reac

2019

Other Studies

1 other study available for opc 12759 and Adverse Drug Event

ArticleYear
The risk of pulmonary adverse drug reactions of rebamipide and other drugs for acid-related diseases: An analysis of the national pharmacovigilance database in South Korea.
    Journal of digestive diseases, 2022, Volume: 23, Issue:2

    Topics: Adverse Drug Reaction Reporting Systems; Aged; Alanine; Databases, Factual; Drug-Related Side Effect

2022